SEC Form 4 · accession 0001179110-18-009534
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mary Fisher
Director
Period of report
Jul 4, 2018
Accepted (ET)
Jul 6, 2018 · 6:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001544227
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.9548 | Jul 4, 2018 | A | 12,000 | A | — | Jul 4, 2028 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018.